Literature DB >> 11971047

What are the determinants of quality of life in people with cervical dystonia?

Y Ben-Shlomo1, L Camfield, T Warner.   

Abstract

BACKGROUND: Little is known about the quality of life in patients with cervical dystonia, although pain and depression are relatively common.
OBJECTIVE: To test the hypothesis that an individual's ability to cope with the disease will modify the association of intrinsic, extrinsic, and disease related factors with quality of life.
METHODS: Patients with cervical dystonia diagnosed by a movement disorder specialist were recruited from seven European countries. Data on quality of life (SF-36), measures of coping, and intrinsic, extrinsic, and disease related factors were collected by a self completed postal questionnaire.
RESULTS: 289 patients (101 men and 188 women), mean age 55 years, completed the questionnaire. Both physical and mental quality of life scores were predicted by self esteem and self deprecation, educational level, employment status, social support, response to botulinum toxin, disease severity, social participation, stigma, acceptance of illness, anxiety, and depression. In multivariable analyses, the strongest predictors were anxiety and depression. Severe depression was associated with a 19.1 point decrement in the physical summary score (95% confidence interval, -31.7 to -6.6; p = 0.003); however, disease duration and severity remained predictors.
CONCLUSIONS: Care for patients with cervical dystonia must not only focus on reducing the severity of the dystonia but also on the psychological wellbeing of the patient. Interventions aimed at treating depression or anxiety, especially of a cognitive nature, may have a large impact on improving quality of life.

Entities:  

Mesh:

Year:  2002        PMID: 11971047      PMCID: PMC1737851          DOI: 10.1136/jnnp.72.5.608

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  32 in total

1.  Depression in Parkinson's disease.

Authors:  H Allain; S Schuck; N Mauduit
Journal:  BMJ       Date:  2000-05-13

2.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

Review 3.  Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease.

Authors:  J R Slaughter; K A Slaughter; D Nichols; S E Holmes; M P Martens
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2001       Impact factor: 2.198

4.  Health status of people with epilepsy compared with a general reference population.

Authors:  K Stavem; J H Loge; S Kaasa
Journal:  Epilepsia       Date:  2000-01       Impact factor: 5.864

5.  Quality of life among stroke survivors evaluated 1 year after stroke: experience of a stroke unit.

Authors:  J Carod-Artal; J A Egido; J L González; E Varela de Seijas
Journal:  Stroke       Date:  2000-12       Impact factor: 7.914

6.  Coping with chronic illness: a study of illness controllability and the influence of coping strategies on psychological adjustment.

Authors:  B J Felton; T A Revenson
Journal:  J Consult Clin Psychol       Date:  1984-06

7.  The influence of social support and perceived control on handicap and quality of life after stroke.

Authors:  A Gottlieb; H Golander; Y Bar-Tal; D Gottlieb
Journal:  Aging (Milano)       Date:  2001-02

8.  The quality of life in Parkinson's disease.

Authors:  A M Kuopio; R J Marttila; H Helenius; M Toivonen; U K Rinne
Journal:  Mov Disord       Date:  2000-03       Impact factor: 10.338

9.  The measurement of helplessness in rheumatoid arthritis. The development of the arthritis helplessness index.

Authors:  P M Nicassio; K A Wallston; L F Callahan; M Herbert; T Pincus
Journal:  J Rheumatol       Date:  1985-06       Impact factor: 4.666

10.  Stigma in patients with rectal cancer: a community study.

Authors:  L D MacDonald; H R Anderson
Journal:  J Epidemiol Community Health       Date:  1984-12       Impact factor: 3.710

View more
  62 in total

1.  Botulinum toxin for writer's cramp: a randomised, placebo-controlled trial and 1-year follow-up.

Authors:  J J M Kruisdijk; J H T M Koelman; B W Ongerboer de Visser; R J de Haan; J D Speelman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-21       Impact factor: 10.154

2.  [Botulinum toxin therapy for spasmodic torticollis: medical and non-medical adjunct treatment].

Authors:  B Leplow; M Böttcher; R Schönfeld
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

Review 3.  The effectiveness of physiotherapy for cervical dystonia: a systematic literature review.

Authors:  Joke De Pauw; Kevin Van der Velden; Jill Meirte; Ulrike Van Daele; Steven Truijen; Patrick Cras; Rudy Mercelis; Willem De Hertogh
Journal:  J Neurol       Date:  2014-01-12       Impact factor: 4.849

4.  Evaluation of anxiety and depression scales and quality of LIFE in cervical dystonia patients on botulinum toxin therapy and their relatives.

Authors:  Dursun Ceylan; Sevda Erer; Mehmet Zarifoğlu; Nevin Türkeş; Güven Özkaya
Journal:  Neurol Sci       Date:  2019-01-18       Impact factor: 3.307

Review 5.  The effect of deep brain stimulation on quality of life in movement disorders.

Authors:  A Diamond; J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

6.  Clinimetric testing of the comprehensive cervical dystonia rating scale.

Authors:  Cynthia L Comella; Joel S Perlmutter; Hyder A Jinnah; Tracy A Waliczek; Ami R Rosen; Wendy R Galpern; Charles A Adler; Richard L Barbano; Stewart A Factor; Christopher G Goetz; Joseph Jankovic; Stephen G Reich; Ramon L Rodriguez; William L Severt; Mateusz Zurowski; Susan H Fox; Glenn T Stebbins
Journal:  Mov Disord       Date:  2016-03-12       Impact factor: 10.338

7.  Mood and energy determinants of quality of life in dystonia.

Authors:  Anne Soeder; Benzi M Kluger; Michael S Okun; Cynthia W Garvan; Thomas Soeder; Charles E Jacobson; Ramon L Rodriguez; Rick Turner; Hubert H Fernandez
Journal:  J Neurol       Date:  2009-03-10       Impact factor: 4.849

8.  Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument.

Authors:  J Müller; J Wissel; G Kemmler; B Voller; T Bodner; A Schneider; G K Wenning; W Poewe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-05       Impact factor: 10.154

Review 9.  Psychiatric comorbidities in dystonia: emerging concepts.

Authors:  Mateusz Zurowski; William M McDonald; Susan Fox; Laura Marsh
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

Review 10.  Primary dystonia: moribund or viable.

Authors:  Susan B Bressman; Rachel Saunders-Pullman
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.